Concepedia

Jorge Blando

JB

Statistics

Publications

60

Citations

11.6K

H-Index

42

Active since

2008

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

The University of Texas at Austin

Baylor College of Medicine

University of Pennsylvania

Memorial Sloan Kettering Cancer Center

Jorge Blando is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, medicine, and cancer immunotherapy.

ORCID

Publications per year

2008–2025

60

Publications

60

B cells and tertiary lymphoid structures promote immunotherapy response

Beth A. Helmink, Sangeetha M. Reddy, Jianjun Gao et al. · Nature · 2020 · 2.7K citations · Full text

, , +16

Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade

Pei-Ling Chen, Whijae Roh, Alexandre Reuben et al. · Cancer Discovery · 2016 · 1K citations · Full text

, , +17

Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma

Rodabe N. Amaria, Sangeetha M. Reddy, Hussein A. Tawbi et al. · Nature Medicine · 2018 · 826 citations · Full text

, , +14

Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis

Yinghong Wang, Diana H. Wiesnoski, Beth A. Helmink et al. · Nature Medicine · 2018 · 721 citations

, , +14

VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer

Jianjun Gao, John F. Ward, Curtis A. Pettaway et al. · Nature Medicine · 2017 · 592 citations

, , +16

1–5 of 60